strategies of AZ & Roche
An outline of the SBU’s historic performance (How has this business been performing within its industry ?) = DONNA
An analysis of the situation the organization is dealing with, with identifying key mega trends in the market and nonmarket (What are the emerging strategic issues within the sector where we compete ?)
An evaluation of the strategic assets of the SBU (What capabilities does the business currently have and might it require ?)

.

A set of breakthrough strategic priorities and how it will be achieved with indicative timescales and outputs of implementation.
Look at other pharma business innovations:
demergers, asset swaps (Glaxo & Novartis)
parallel development/testing process (Merck)
Pfizer business units according to patent expiry time & acquisition attempt
compare AZ & Roche strategy, look for interesting strategies AZ might adopt

.